Related Experiment Video
Updated: Jul 19, 2026

Real-Time Measurement of the Mitochondrial Bioenergetic Profile of Neutrophils
Published on: June 2, 2023
Complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-targeted antioxidants
Juan V Esplugues1, Milagros Rocha, Cristina Nuñez
1Departamento de Farmacologia, Facultad de Medicina, Universitat de Valencia, Spain.
Nitroglycerin tolerance impairs mitochondrial function and aldehyde dehydrogenase-2 activity. Mitochondrial-targeted antioxidants prevent tolerance by protecting complex I from oxidative stress, suggesting a therapeutic role.
Area of Science:
- Pharmacology
- Mitochondrial Biology
- Cardiovascular Research
Background:
- Nitroglycerin (GTN) is widely used for angina, but tolerance limits its chronic efficacy.
- The mechanisms underlying GTN tolerance, particularly mitochondrial dysfunction, remain incompletely understood.
- Oxidative stress within mitochondria is implicated in various pathological conditions.
Purpose of the Study:
- To investigate the role of mitochondrial function and oxidative stress in the development of GTN tolerance.
- To identify specific mitochondrial targets affected by prolonged GTN exposure.
- To evaluate the potential of mitochondrial-targeted antioxidants in preventing GTN tolerance.
Main Methods:
- Induction of GTN tolerance in vivo (rats) and in vitro (vessels, endothelial cells).
- Electrochemical detection of nitric oxide (NO) and oxygen (O2) consumption.
- Assessment of mitochondrial respiration, aldehyde dehydrogenase (ALDH)-2 activity, and reactive oxygen species (ROS) production.
- Intervention with mitochondrial-targeted antioxidants (mitoquinone [MQ]) and glutathione (GSH) ester.
Main Results:
- GTN tolerance decreased mitochondrial O2 consumption and altered its kinetics (Km) in a noncompetitive manner.
- Tolerance was associated with aldehyde dehydrogenase (ALDH)-2 inhibition and mitochondrial uncoupling.
- Mitochondrial-targeted antioxidants (MQ) and GSH ester prevented tolerance and protected mitochondrial function and ALDH-2 activity.
- GTN's effects on mitochondrial respiration were primarily linked to Complex I inhibition, mediated by ROS.
Conclusions:
- Prolonged GTN treatment induces tolerance by impairing mitochondrial Complex I function via ROS-mediated oxidative stress.
- Aldehyde dehydrogenase (ALDH)-2 inhibition and Complex I dysfunction are key mechanisms in GTN tolerance.
- Mitochondrial-targeted antioxidants show promise as a therapeutic strategy to mitigate chronic nitrate tolerance.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Antianginal Drugs: Nitrates and β-Blockers
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Heart Failure Drugs: Inotropic Agents
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Angina IV: Management
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q in...

